Vaccine compositions and methods

Details for Australian Patent Application No. 2005251818 (hide)

Owner CureLab, Inc.

Inventors Sherman, Michael; Shneider, Alexander M.

Agent Freehills

Pub. Number AU-A-2005251818

PCT Pub. Number WO2005/120564

Priority 10/866,484 11.06.04 US

Filing date 13 June 2005

Wipo publication date 22 December 2005

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2005/120564 Priority application(s): WO2005/120564

21 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251820-HIV integrase inhibitors

2005251816-Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease